ABSTRACT
Therefore, we define as autoimmune GDM a concrete subgroup of women depicting humoral autoimmune markers against pancreatic cells in association with glucose intolerance at pregnancy. Due to its potential high risk for progression to clinically overt insulinopenia, women with autoimmune GDM may be considered candidates for immune interventions.
